5.24 Pentostatin, Alemtuzumab, and Low-Dose Rituximab Is Effective Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
2011 ◽
Vol 11
◽
pp. S261
◽
2004 ◽
Vol 45
(3)
◽
pp. 507-513
◽
Keyword(s):
2003 ◽
Vol 119
(6)
◽
pp. 824-832
◽
2012 ◽
Vol 53
(4)
◽
pp. 589-595
◽